Association of First Metatarsal Phalangeal Joint Fusion for Hallux Rigidus With Patient-Reported Pain and Mental Health Outcomes in Patients Taking Psychotropic Medications

Background: Limited literature examines the relationship between surgical outcomes in chronic foot and ankle conditions and concurrent psychiatric care. The present study aimed to investigate patient-reported and surgical outcomes of patients treated for a psychiatric disorder undergoing first metat...

Full description

Bibliographic Details
Main Authors: Wesley J. Manz MD, MS, Juliet Fink BA, Joseph Novack BA, Joseph Jacobson MD, Jason T. Bariteau MD
Format: Article
Language:English
Published: SAGE Publishing 2023-03-01
Series:Foot & Ankle Orthopaedics
Online Access:https://doi.org/10.1177/24730114231157731
_version_ 1797861978413203456
author Wesley J. Manz MD, MS
Juliet Fink BA
Joseph Novack BA
Joseph Jacobson MD
Jason T. Bariteau MD
author_facet Wesley J. Manz MD, MS
Juliet Fink BA
Joseph Novack BA
Joseph Jacobson MD
Jason T. Bariteau MD
author_sort Wesley J. Manz MD, MS
collection DOAJ
description Background: Limited literature examines the relationship between surgical outcomes in chronic foot and ankle conditions and concurrent psychiatric care. The present study aimed to investigate patient-reported and surgical outcomes of patients treated for a psychiatric disorder undergoing first metatarsophalangeal (MTP) fusion for hallux rigidus. We hypothesized that patients on psychotropic medications would have greater subjective pain preoperatively and less improvement in physical and mental functionality postoperatively when compared with nonmedicated patients. Methods: A single-center, retrospective review of prospectively collected data was conducted on 92 patients undergoing first MTP fusion with a preoperative diagnosis of hallux rigidus from 2015 to 2019. At their preoperative, 6-month postoperative, and 1-year postoperative visits, patients were administered visual analog pain scale (VAS) and 36-Item Short Form Health Survey (SF-36) functionality surveys. Patients were subsequently identified by chronic use of psychotropic medication preoperatively and grouped for analysis (MED, n = 42; NO MED, n = 50). Results: Postoperative mean VAS pain scores were lower for all studied patients at 6 months (VAS = 1.6 ± 2.3) and 1 year postoperatively (VAS = 1.1± 1.8) relative to the preoperative visit (VAS = 4.7 ± 2.8) ( P  ≤ .0001 and P  ≤ .0001, respectively). No differences in mean VAS pain scores nor SF-36 physical component summary scores were detected at preoperative, 6-month, or 1-year visits between NO MED and MED groups. Mean SF-36 mental component summary scores for those in the MED group were lower at preoperative (NO MED = 83.8, MED = 71.8, P  = .006) and 6-month postoperative (NO MED = 86.1, MED = 72.7, P  = .037) visits than those in the NO MED group, a trend not observed at the 1-year postoperative mark (NO MED = 84.1, MED = 76.8, P  = .228). There were no observed differences in operative time ( P  = .219), tourniquet time ( P  = .359), nor time to full weightbearing ( P  = .512) between MED and NO MED groups. Additionally, no differences in postoperative complication rates were observed between groups. Conclusion: In patients treated with psychotropically active medications with hallux rigidus, MTP Fusion appears to be a reasonable treatment choice with similar outcomes for patients requiring psychotropically active medications to the outcomes of those patients not requiring psychotropically active medications. Level of Evidence: Level III, retrospective comparative study.
first_indexed 2024-04-09T22:13:00Z
format Article
id doaj.art-9ade29fb563a450d81afbfaff16f78a2
institution Directory Open Access Journal
issn 2473-0114
language English
last_indexed 2024-04-09T22:13:00Z
publishDate 2023-03-01
publisher SAGE Publishing
record_format Article
series Foot & Ankle Orthopaedics
spelling doaj.art-9ade29fb563a450d81afbfaff16f78a22023-03-23T07:33:19ZengSAGE PublishingFoot & Ankle Orthopaedics2473-01142023-03-01810.1177/24730114231157731Association of First Metatarsal Phalangeal Joint Fusion for Hallux Rigidus With Patient-Reported Pain and Mental Health Outcomes in Patients Taking Psychotropic MedicationsWesley J. Manz MD, MS0Juliet Fink BA1Joseph Novack BA2Joseph Jacobson MD3Jason T. Bariteau MD4Department of Orthopaedic Surgery, Emory University School of Medicine, Atlanta, GA, USAEmory University School of Medicine, Atlanta, GA, USAEmory University School of Medicine, Atlanta, GA, USADepartment of Orthopaedic Surgery, Emory University School of Medicine, Atlanta, GA, USADepartment of Orthopaedic Surgery, Emory University School of Medicine, Atlanta, GA, USABackground: Limited literature examines the relationship between surgical outcomes in chronic foot and ankle conditions and concurrent psychiatric care. The present study aimed to investigate patient-reported and surgical outcomes of patients treated for a psychiatric disorder undergoing first metatarsophalangeal (MTP) fusion for hallux rigidus. We hypothesized that patients on psychotropic medications would have greater subjective pain preoperatively and less improvement in physical and mental functionality postoperatively when compared with nonmedicated patients. Methods: A single-center, retrospective review of prospectively collected data was conducted on 92 patients undergoing first MTP fusion with a preoperative diagnosis of hallux rigidus from 2015 to 2019. At their preoperative, 6-month postoperative, and 1-year postoperative visits, patients were administered visual analog pain scale (VAS) and 36-Item Short Form Health Survey (SF-36) functionality surveys. Patients were subsequently identified by chronic use of psychotropic medication preoperatively and grouped for analysis (MED, n = 42; NO MED, n = 50). Results: Postoperative mean VAS pain scores were lower for all studied patients at 6 months (VAS = 1.6 ± 2.3) and 1 year postoperatively (VAS = 1.1± 1.8) relative to the preoperative visit (VAS = 4.7 ± 2.8) ( P  ≤ .0001 and P  ≤ .0001, respectively). No differences in mean VAS pain scores nor SF-36 physical component summary scores were detected at preoperative, 6-month, or 1-year visits between NO MED and MED groups. Mean SF-36 mental component summary scores for those in the MED group were lower at preoperative (NO MED = 83.8, MED = 71.8, P  = .006) and 6-month postoperative (NO MED = 86.1, MED = 72.7, P  = .037) visits than those in the NO MED group, a trend not observed at the 1-year postoperative mark (NO MED = 84.1, MED = 76.8, P  = .228). There were no observed differences in operative time ( P  = .219), tourniquet time ( P  = .359), nor time to full weightbearing ( P  = .512) between MED and NO MED groups. Additionally, no differences in postoperative complication rates were observed between groups. Conclusion: In patients treated with psychotropically active medications with hallux rigidus, MTP Fusion appears to be a reasonable treatment choice with similar outcomes for patients requiring psychotropically active medications to the outcomes of those patients not requiring psychotropically active medications. Level of Evidence: Level III, retrospective comparative study.https://doi.org/10.1177/24730114231157731
spellingShingle Wesley J. Manz MD, MS
Juliet Fink BA
Joseph Novack BA
Joseph Jacobson MD
Jason T. Bariteau MD
Association of First Metatarsal Phalangeal Joint Fusion for Hallux Rigidus With Patient-Reported Pain and Mental Health Outcomes in Patients Taking Psychotropic Medications
Foot & Ankle Orthopaedics
title Association of First Metatarsal Phalangeal Joint Fusion for Hallux Rigidus With Patient-Reported Pain and Mental Health Outcomes in Patients Taking Psychotropic Medications
title_full Association of First Metatarsal Phalangeal Joint Fusion for Hallux Rigidus With Patient-Reported Pain and Mental Health Outcomes in Patients Taking Psychotropic Medications
title_fullStr Association of First Metatarsal Phalangeal Joint Fusion for Hallux Rigidus With Patient-Reported Pain and Mental Health Outcomes in Patients Taking Psychotropic Medications
title_full_unstemmed Association of First Metatarsal Phalangeal Joint Fusion for Hallux Rigidus With Patient-Reported Pain and Mental Health Outcomes in Patients Taking Psychotropic Medications
title_short Association of First Metatarsal Phalangeal Joint Fusion for Hallux Rigidus With Patient-Reported Pain and Mental Health Outcomes in Patients Taking Psychotropic Medications
title_sort association of first metatarsal phalangeal joint fusion for hallux rigidus with patient reported pain and mental health outcomes in patients taking psychotropic medications
url https://doi.org/10.1177/24730114231157731
work_keys_str_mv AT wesleyjmanzmdms associationoffirstmetatarsalphalangealjointfusionforhalluxrigiduswithpatientreportedpainandmentalhealthoutcomesinpatientstakingpsychotropicmedications
AT julietfinkba associationoffirstmetatarsalphalangealjointfusionforhalluxrigiduswithpatientreportedpainandmentalhealthoutcomesinpatientstakingpsychotropicmedications
AT josephnovackba associationoffirstmetatarsalphalangealjointfusionforhalluxrigiduswithpatientreportedpainandmentalhealthoutcomesinpatientstakingpsychotropicmedications
AT josephjacobsonmd associationoffirstmetatarsalphalangealjointfusionforhalluxrigiduswithpatientreportedpainandmentalhealthoutcomesinpatientstakingpsychotropicmedications
AT jasontbariteaumd associationoffirstmetatarsalphalangealjointfusionforhalluxrigiduswithpatientreportedpainandmentalhealthoutcomesinpatientstakingpsychotropicmedications